March 29, 2023 - CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER FIRM OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - 20-F: Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) | CollPlant Biotechnologies Ltd. (CLGN)

Form: 20-F

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

March 29, 2023

Documents

Exhibit 15.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1) Registration Statements (Form F-3 No. 333-228054, 333-238731, and 333-269087) of CollPlant Biotechnologies Ltd., and in the related Prospectuses, and
(2) Registration Statements (Form S-8 No. 333-229163, 333-248479 and 333-263842) pertaining to the Share Ownership and Option Plan (2010) of CollPlant Biotechnologies Ltd.;

 

of our report dated March 29, 2023, with respect to the consolidated financial statements of CollPlant Biotechnologies Ltd. included in this Annual Report (Form 20-F) for the year ended December 31, 2022.

 

  /s/ Kost Forer Gabbay & Kasierer

Tel Aviv, Israel

 Kost Forer Gabbay & Kasierer

March 29, 2023

A Member of Ernst & Young Global